Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gyon Technologies Capital Management LP lessened its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 59.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,431 shares of the biotechnology company’s stock after selling 7,994 shares during […]
Epoch Investment Partners Inc. reduced its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 26.4% in the 4th quarter, HoldingsChannel.com reports. The firm owned 198,798 shares of the biotechnology company’s stock after selling 71,344 shares during the quarter. Epoch Investment Partners Inc.’s holdings in United Therapeutics were worth $55,284,000 at the […]
Shelton Capital Management lessened its holdings in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 2.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,313 shares of the biotechnology company’s stock after selling 66 shares during the period. Shelton […]
Quadrant Capital Group LLC grew its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 50.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 511 shares of the biotechnology company’s stock after purchasing an additional 171 shares during […]
ExodusPoint Capital Management LP raised its holdings in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 326.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 124,507 shares of the biotechnology company’s stock after buying an additional 95,310 […]